Literature DB >> 19254985

Outcomes of meningococcal disease in adolescence: prospective, matched-cohort study.

Jennie Borg1, Deborah Christie, Pietro G Coen, Robert Booy, Russell M Viner.   

Abstract

OBJECTIVE: We examined the physical, cognitive, educational, social, and psychological outcomes of invasive meningococcal disease in adolescence, as well as demographic and disease factors associated with outcomes.
METHODS: A population-based, matched-cohort study was performed. A total of 101 gender- and age-matched case-control pairs (15-19 years of age at the time of disease; 46% male) from 6 regions of England underwent follow-up evaluations 18 to 36 months after invasive meningococcal disease. Educational, social, and vocational function, mental health, social support, self-efficacy, and quality-of-life data were collected by using standardized questionnaires and neuropsychological tests.
RESULTS: Fifty-seven percent of case subjects (n = 58) had major physical sequelae. Survivors had greater depressive symptoms, greater fatigue, less social support, greater reduction in quality of life, and lower educational attainment compared with control subjects. Survivors with serogroup C disease had greater physical sequelae than did those with serogroup B disease. Greater cognitive deficits were associated with younger age at diagnosis. Only 53 of 101 case subjects reported any medical follow-up care after invasive meningococcal disease.
CONCLUSIONS: Survivors of invasive meningococcal disease in adolescence have a disturbing series of deficits, including poorer physical and mental health, quality of life, and educational achievement. Serogroup C is associated with poorer outcomes. Invasive meningococcal disease attributable to serogroup B disease remains a major cause of morbidity and death among adolescents. Medical care is poor after discharge from the hospital. Routine follow-up care of adolescent survivors may prevent or ameliorate physical and psychosocial morbidity after invasive meningococcal disease.

Entities:  

Mesh:

Year:  2009        PMID: 19254985     DOI: 10.1542/peds.2008-0581

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  22 in total

Review 1.  Pre-admission antibiotics for suspected cases of meningococcal disease.

Authors:  Thambu D Sudarsanam; Priscilla Rupali; Prathap Tharyan; Ooriapadickal Cherian Abraham; Kurien Thomas
Journal:  Cochrane Database Syst Rev       Date:  2017-06-14

Review 2.  Invasive meningococcal disease in the 21st century—an update for the clinician.

Authors:  Rachel Dwilow; Sergio Fanella
Journal:  Curr Neurol Neurosci Rep       Date:  2015-03       Impact factor: 5.081

3.  Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules.

Authors:  Manish Sadarangani; Tim Sell; Mildred A Iro; Matthew D Snape; Merryn Voysey; Adam Finn; Paul T Heath; Gianni Bona; Susanna Esposito; Javier Diez-Domingo; Roman Prymula; Adefowope Odueyungbo; Daniela Toneatto; Andrew J Pollard
Journal:  CMAJ       Date:  2017-10-16       Impact factor: 8.262

4.  Fatigue following Paediatric Acquired Brain Injury and its Impact on Functional Outcomes: A Systematic Review.

Authors:  Jake Wilkinson; Nohely Lee Marmol; Celia Godfrey; Harriet Wills; Quirine van Eijndhoven; Edith Nardu Botchway; Nikita Sood; Vicki Anderson; Cathy Catroppa
Journal:  Neuropsychol Rev       Date:  2018-03-19       Impact factor: 7.444

5.  Long-term sequelae of childhood bacterial meningitis.

Authors:  Lee D Hudson; Russell M Viner; Deborah Christie
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

Review 6.  Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease.

Authors:  Darryl J Hill; Natalie J Griffiths; Elena Borodina; Mumtaz Virji
Journal:  Clin Sci (Lond)       Date:  2010-02-09       Impact factor: 6.124

Review 7.  Meningococcal vaccination in pregnancy.

Authors:  Bahaa Abu Raya; Manish Sadarangani
Journal:  Hum Vaccin Immunother       Date:  2018-03-21       Impact factor: 3.452

8.  A population-based prospective birth cohort study of childhood neurocognitive and psychological functioning in healthy survivors of early life meningitis.

Authors:  Golam M Khandaker; Jan Stochl; Stanley Zammit; Glyn Lewis; Peter B Jones
Journal:  Ann Epidemiol       Date:  2014-11-20       Impact factor: 3.797

9.  Comparative long-term adverse effects elicited by invasive group B and C meningococcal infections.

Authors:  Magnus Gottfredsson; Ingi K Reynisson; Ragnar F Ingvarsson; Hafrun Kristjansdottir; Martina V Nardini; Jon F Sigurdsson; Rachel Schneerson; John B Robbins; Mark A Miller
Journal:  Clin Infect Dis       Date:  2011-09-26       Impact factor: 9.079

Review 10.  Chemoprophylaxis and vaccination in preventing subsequent cases of meningococcal disease in household contacts of a case of meningococcal disease: a systematic review.

Authors:  L Telisinghe; T D Waite; M Gobin; O Ronveaux; K Fernandez; J M Stuart; R J P M Scholten
Journal:  Epidemiol Infect       Date:  2015-04-28       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.